John J. Cannon III


Mr. Cannon is a partner in the Compensation, Governance and ERISA Group and Co-Chair of the firm’s Corporate Governance Advisory Group.  In his practice, he focuses on all aspects of compensation and benefits, including corporate, securities, bankruptcy, employment and tax laws and ERISA. He has extensive experience in executive compensation and corporate governance matters, Dodd-Frank and Sarbanes-Oxley, and the employee issues raised in the mergers and acquisitions context.  He also has experience in matters relating to employee stock ownership plans (ESOPs), including in both the transactional context and in ERISA-based based litigation. Mr. Cannon joined the firm in 1985 and became a partner in 1994.

Selected Experience

  • Pall Corporation in its acquisition by Danaher Corporation
  • Boston Scientific Corporation in its acquisition of the men’s health business of Endo International’s American Medical Systems
  • Textron Inc. in its acquisition of Beechcraft
  • The review committee of the Board of Directors of JPMorgan Chase & Co. in connection with the “London Whale” matter
  • B/E Aerospace in the spin-off of KLX Inc.

Recent Publications

  • “Just Say No: Why Directors Should Avoid Duties That Will Subject Them to ERISA,” Bloomberg BNA’s Corporate Law & Accountability Report, February 20, 2015
  • “In re Trados: Directors Dodge a Bullet,” in Shearman & Sterling LLP Corporate Governance Newsletter, December 2013
  • “Stock Options and Beyond” (with Mark Kessel), Nature Biotechnology 31, 676-680 (2013)


  • New York University School of Law, J.D., 1985
  • Harvard College, A.B., 1980


Connect With Us